Cite

HARVARD Citation

    Maesaka, F. et al. (2019). Amrubicin is effective against small cell carcinoma of the prostate as a second‐line chemotherapeutic agent: A case report. IJU case reports. 2 (3), pp. 133-136. [Online]. 
  
Back to record